Neurocrine Biosciences(NBIX) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist

110.870
-2.170-1.92%

Close Mar 10 16:00 ET

110.000
-0.870-0.78%

Post 20:01 ET

11.05BMarket Cap33.70P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Dividend 'Hopefuls' – Stocks Have the Ability to Pay Dividends but Don't
Seeking AlphaMar 7 14:10 ET
Neurocrine Coverage Assumed by Morgan Stanley at Overweight
Dow JonesMar 7 12:49 ET
Express News | Neurocrine Biosciences Inc : Morgan Stanley Cuts Target Price to $150.00 From $185.00
ReutersMar 7 07:44 ET
Morgan Stanley Initiates Neurocrine Biosciences(NBIX.US) With Buy Rating, Announces Target Price $150
Moomoo NewsMar 7 07:35 ET · Ratings
Positive Growth Outlook for Neurocrine Biosciences Driven by Ingrezza and Crenessity Sales Projections
TipRanksMar 7 07:06 ET
What You Can Learn From Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) P/E After Its 26% Share Price Crash
Simply Wall StMar 7 06:20 ET

Comments

Teddy123

Mar 5 07:51

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBI-1140675, a Second-Generation VMAT2 Inhibitor, in Healthy Adults

$Neurocrine Biosciences (NBIX.US)$
Can Neurocrine's New VMAT2 Inhibitor Replicate Its Previous FDA Success? Phase 1 Trial Launches

Kevin Travers

Feb 7 15:05

Columns Wall Street Today: One More Earnings Week Down

Overall, the market traded lower Friday, after a week of trade and earnings upsets.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded down 0.95%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.99%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 1.36%.
MACRO
Macroeconomic news might have swayed the market as jobs and unemployment data came in. The economy added 143,000 jobs in January, according to the BLS, which was low, but N...

Live Stock Financial Podcast. What are you watching on the market?

Meltyy

Dec 17, 2024 01:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...